Nanjing Changao Pharmaceutical Science and Technology Co., Limited received the supplemental approval for the consistency evaluation of calcium dobesilate tablets.

Nanjing Chang Ao Pharmaceutical Co., Limited underwent and successfully passed drug GMP follow-up inspection from September 13 to 16.

Nanjing Chang Ao Pharmaceutical Co., Limited carried out grade 2 safety standardization review.

Pitavastatin calcium tablets successfully won the bid for VBP in August. Nanjing Chang Ao Pharmaceutical Co., Limited is active in responding the bid and subsequent production, and now the variety concerned has been put into production.